preview

Financial Management and Analysis

Better Essays

Financial Management and Analysis

Table of Contents

Introduction 3
Presentation of the companies 3
Ratio analysis of the companies 5
Profitability ratios 5
Liquidity ratios 7
Efficiency ratios 9
Gearing ratios 11
Investment ratios 12
Ratio analysis strengths and weaknesses 14

Introduction

Financial analysis involves the use of various financial statements, which perform several functions. Basics of financial analysis consist of a balance sheet and income statement. Income statement shows revenues and expenditures of enterprises over a certain period of time, usually for one year or semester. Balance sheet shows the assets, liabilities and owner's equity at a specific point in time (usually at the end of the …show more content…

The company also has a broad spectrum of products in various stages of development. Biogen Idec has direct operations in 33 countries and a network of distributors in over 70 other markets on five continents. Biogen Idec is headquartered in Cambridge Massachusetts. (http://www.biogenidec.com/about_history.aspx?ID=5480)

Ratio analysis of the companies

Ratios numbers allow us to better understand the current financial position of the company and to compare it with competing firms. All ratio numbers can be classified into several groups of related financial ratios. This classification is not uniform and depends on the analyst. In this report, rational numbers will be grouped in:
• Profitability ratios
• Liquidity ratios
• Efficiency ratios
• Financial ratios
• Investor ratios

Profitability ratios

Average profitability ratios in Pharmaceutical Industry 2013 2012 2011 2010 2009
Return on Equity (ROE) 18.99% 19.24% 18.75% 16.63% 21.22%
Return on Assets (ROA) 8.86% 8.65% 8.78% 8.04% 10.22%
Operating Profit Margin 20.09% 21.50% 21.06% 20.34% 22.02%
Source: www.stock-analysis-on.net

Celgene, profitability ratios 2013 2012 2011 2010 2009
Return on Equity (ROE) 25.94% 25.57% 23.91% 14.71% 17.68%
Return on Assets (ROA) 10.84% 12.41% 13.17% 8.65% 14.41%
Operating Profit Margin 28.43% 32.43% 30.70% 28.21% 32.78%
Source: Based on data from Celgene Corp. Annual Reports

ROE - Celgene

Get Access